Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02196038 · ClinicalTrials.gov registry record · NA
A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT02196038 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 349 participants.
The verdict
NCT02196038, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention administered to older patients with acute decompensated heart failure (ADHF) beginning early during hospitalization and continuing for 12 weeks will improve physical function and key clinical outcomes, including the rate of rehospitalization.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL multi-domain rehabilitation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-07-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02196038
The ClinicalTrials.gov registry entry for NCT02196038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT02196038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02196038 about?
NCT02196038 is a clinical study titled "A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients". REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention ad...
What is the current status of trial NCT02196038?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2014-09. Estimated completion is 2020-07-27.
What interventions are being tested in trial NCT02196038?
The interventions under investigation include: Attention Control (BEHAVIORAL), multi-domain rehabilitation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02196038?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.